However, the muscle proteome analysis of Facioscapulohumeral dystrophy patients reveals decreased FBP2, whereas the upregulation of FBP2 was found in our study, indicating the distinct molecular mechanisms underlying muscle atrophy in various muscle atrophy models [33]. This evidence concerns the gene FBP2 and Facioscapulohumeral dystrophy.